Parallel dose-response curves in combination experiments.
A possible experimental design for combination experiments is to compare the dose-response curve of a single agent with the corresponding curve of the same agent using either a fixed amount of a second one or a fixed dose ratio. No interaction is then often defined by a parallel shift of these curves. We have performed a systematic study for various types of dose-response relations both for the dose-additivity (Loewe additivity) and for the independence (Bliss independence) criteria for defining zero interaction. Parallelism between dose-response curves of a single agent and those of the same agent in the presence of a fixed amount of another one is found for the Loewe-additivity criterion for linear dose-response relations. For nonlinear relations, one has to differentiate between effect parallelism (parallel shift on the effect scale) and dose parallelism (parallel shift on the dose scale). In the case of Loewe additivity, zero-interaction dose parallelism is found for power, Weibull, median-effect and logistic dose-response relations, given that special parameter relationships are fulfilled. The mechanistic model of competitive interaction exhibits dose parallelism but not effect parallelism for Loewe additivity. Bliss independence and Loewe additivity lead to identical results for exponential dose-response curves. This is the only case for which dose parallelism was found for Bliss independence. Parallelism between single-agent dose-response relations and Loewe additivity mixture relations is found for examples with a fixed dose-ratio design. However, this is again not a general property of the design adopted but holds only if special conditions are fulfilled. The comparison of combination dose-response curves with single-agent relations has to be performed taking into account both potency and shape parameters. The results of this analysis lead to the conclusion that parallelism between zero interaction combination and single-agent dose-response relations is found only for special cases and cannot be used as a general criterion for defining zero-interaction in combined-action assessment even if the correct potency shift is taken into account.
Sühnel
J
J
Institut für Molekulare Biotechnologie, Jena, Germany. jsuehnel@imb-jena.de
D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D016014:Linear Models; D016015:Logistic Models; D008954:Models, Biological; D017711:Nonlinear Dynamics